2014 - Fellow, National Academy of Inventors
2012 - Fellow of the American Academy of Arts and Sciences
2004 - Distinguished Scientist Award, American Heart Association
1998 - Member of the National Academy of Medicine (NAM)
Member of the European Academy of Sciences and Arts
Member of the Association of American Physicians
Victor J. Dzau mainly focuses on Internal medicine, Endocrinology, Angiotensin II, Renin–angiotensin system and Molecular biology. His biological study spans a wide range of topics, including Biophysics and Cardiology. His Endocrinology research is multidisciplinary, incorporating elements of Growth factor and Autocrine signalling.
The study incorporates disciplines such as Muscle hypertrophy, Pharmacology and Mechanism of action in addition to Angiotensin II. His work in Renin–angiotensin system covers topics such as Messenger RNA which are related to areas like RNA. His Molecular biology research also works with subjects such as
His primary areas of investigation include Internal medicine, Endocrinology, Renin–angiotensin system, Cell biology and Molecular biology. His Cardiology research extends to the thematically linked field of Internal medicine. His research integrates issues of Biochemistry, Enzyme, Messenger RNA, Antibody and Kidney in his study of Renin–angiotensin system.
His studies deal with areas such as Reprogramming, Paracrine signalling and In vivo as well as Cell biology. His Paracrine signalling research integrates issues from Protein kinase B and Programmed cell death. His Molecular biology study combines topics from a wide range of disciplines, such as Gene expression and Transfection.
Victor J. Dzau mainly focuses on Cell biology, MEDLINE, Global health, Health care and Reprogramming. He has included themes like Cellular differentiation, microRNA and Paracrine signalling in his Cell biology study. His Paracrine signalling research focuses on Protein kinase B and how it relates to Stem cell factor.
In his study, Disease is inextricably linked to Precision medicine, which falls within the broad field of Health care. His study in Reprogramming is interdisciplinary in nature, drawing from both Histone methyltransferase, Gene knockdown, Transcription factor, Molecular biology and Myocyte. His Mesenchymal stem cell study integrates concerns from other disciplines, such as Endocrinology, Kidney, Internal medicine and CD44.
Victor J. Dzau mainly investigates Cell biology, Health care, Global health, MEDLINE and Stem cell. Victor J. Dzau interconnects Cell growth, Cellular differentiation, Reprogramming, Molecular biology and microRNA in the investigation of issues within Cell biology. The Cellular differentiation study combines topics in areas such as Paracrine Communication, Juxtaglomerular apparatus, Kidney, Juxtaglomerular cell and Mesenchymal stem cell.
His Stem cell research incorporates themes from Obesity, Pathology, Paracrine signalling, Regeneration and Adipogenesis. His study in Paracrine signalling is interdisciplinary in nature, drawing from both Stem cell factor and Protein kinase B. Victor J. Dzau has researched Protein kinase B in several fields, including Cytoprotection, Programmed cell death and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Emerging Concept of Vascular Remodeling
Gary H. Gibbons;Victor J. Dzau.
The New England Journal of Medicine (1994)
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
Massimiliano Gnecchi;Zhiping Zhang;Aiguo Ni;Victor J. Dzau.
Circulation Research (2008)
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts
Abeel A Mangi;Nicolas Noiseux;Deling Kong;Huamei He.
Nature Medicine (2003)
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
Massimiliano Gnecchi;Massimiliano Gnecchi;Huamei He;Olin D Liang;Luis G Melo;Luis G Melo;Luis G Melo.
Nature Medicine (2005)
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement
Massimiliano Gnecchi;Huamei He;Nicolas Noiseux;Olin D. Liang.
The FASEB Journal (2006)
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.
Mark A. Creager;John P. Cooke;Michael E. Mendelsohn;Shelly J. Gallagher.
Journal of Clinical Investigation (1990)
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
Victor J. Dzau;Ruediger C. Braun-Dullaeus;Daniel G. Sedding.
Nature Medicine (2002)
The heart in hypertension.
Edward D. Frohlich;Carl Apstein;Aram V. Chobanian;Richard B. Devereux.
The New England Journal of Medicine (1992)
Tissue Angiotensin and Pathobiology of Vascular Disease A Unifying Hypothesis
Victor J. Dzau.
Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors.
Masashi Mukoyama;Masatoshi Nakajima;Masatsugu Horiuchi;Hiroyuki Sasamura.
Journal of Biological Chemistry (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: